Antiobesity effect of Pediococcus pentosaceus LP28 on overweight subjects: a randomized, double-blind, placebo-controlled clinical trial

@article{Higashikawa2016AntiobesityEO,
  title={Antiobesity effect of Pediococcus pentosaceus LP28 on overweight subjects: a randomized, double-blind, placebo-controlled clinical trial},
  author={Fumiko Higashikawa and Masafumi Noda and Tomokazu Awaya and Narandalai Danshiitsoodol and Yuka Matoba and Takako Kumagai and Masanori Sugiyama},
  journal={European Journal of Clinical Nutrition},
  year={2016},
  volume={70},
  pages={582-587}
}
Background/Objectives:The population of the obese is increasing worldwide. Prevention and improvement of obesity are indispensable for decreasing the risk of metabolic disorders. We have recently shown that obesity and fatty liver are reduced by a plant-derived lactic acid bacterium, Pediococcus pentosaceus LP28 (LP28), in high-fat diet-induced obese mice. The aim of the present clinical study is to prove that LP28 is effective for reducing body fat and body weight, as shown in the experiment… CONTINUE READING